Agilent Technologies Inc at JPMorgan Healthcare Conference Transcript
All right. Great. Welcome, everybody, to the JPMorgan Healthcare Conference. I'm Casey Woodring from the life science tools and diagnostics team. Pleased to be joined by the management team of Agilent.
Padraig will go through the corporate presentation here, then we'll leave time for Q&A afterwards. The floor is yours.
Yeah. Thanks, Casey, and good morning, everybody. So welcome and thanks for joining. Delighted to be here to talk about Agilent. But first, before we get started, a quick important reminder from our legal department, a safe harbor statement. So getting into it, one, if you remember nothing else about the Agilent story, here are five key points that I want to take you through on how we're delivering growth, gaining market share and how that translates for all stakeholders.
First, we are in very large attractive markets with excellent growth potential and many secular drivers within those markets.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
